Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?

Por Nathan, Steven D, King, Christopher S
Publicado em 2014

IPF clinical trial design and endpoints

Por Nathan, Steven D., Meyer, Keith C.
Publicado em 2014

Response

Por Nathan, Steven D., Brown, A. Whitney, Weir, Nargues A.
Publicado em 2014

Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis

Por Reichmann, William M., Yu, Yanni F., Macaulay, Dendy, Wu, Eric Q., Nathan, Steven D.
Publicado no BMC Pulm Med (2015)

Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis

Por SWIGRIS, Jeffrey J., OLSON, Amy L., SHLOBIN, Oksana A., AHMAD, Shahzad, BROWN, Kevin K., NATHAN, Steven D.
Publicado em 2011

Glucose Transporter-1 Distribution in Fibrotic Lung Disease: Association With [(18)F]-2-Fluoro-2-Deoxyglucose-PET Scan Uptake, Inflammation, and Neovascularization

Por El-Chemaly, Souheil, Malide, Daniela, Yao, Jianhua, Nathan, Steven D., Rosas, Ivan O., Gahl, William A., Moss, Joel, Gochuico, Bernadette R.
Publicado em 2013

Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension

Por Weinstein, Ali A., Chin, Lisa M.K., Keyser, Randall E., Kennedy, Michelle, Nathan, Steven D., Woolstenhulme, Joshua G., Connors, Gerilynn, Chan, Leighton
Publicado em 2013

Hemothorax following lung transplantation: incidence, risk factors, and effect on morbidity and mortality

Por Hong, Aria, King, Christopher S., Brown, A. Whitney Walter, Ahmad, Shahzad, Shlobin, Oksana A., Khandhar, Sandeep, Bogar, Linda, Rongione, Anthony, Nathan, Steven D.
Publicado no Multidiscip Respir Med (2016)

CARDIORESPIRATORY FUNCTION BEFORE AND AFTER AEROBIC EXERCISE TRAINING IN PATIETNS WITH INTERSTITIAL LUNG DISEASE

Por Keyser, Randall E., Woolstenhulme, Joshua G., Chin, Lisa M.K., Nathan, Steven D., Weir, Nargues A., Connors, Gerilynn, Drinkard, Bart, Lamberti, James, Chan, Leighton
Publicado no J Cardiopulm Rehabil Prev (2015)

A critical assessment of treatment options for idiopathic pulmonary fibrosis

Por Shah, Nirav R., Noble, Paul, Jackson, Robert M., King, Talmadge E., Nathan, Steven D., Padilla, Maria, Raghu, Ganesh, Rhodes, Melissa Bruce, Schwarz, Marvin, Tino, Gregory, Dubois, Robert W.
Publicado em 2005

Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis

Por Nathan, Steven D., Shlobin, Oksana A., Barnett, Scott D., Saggar, Rajeev, Belperio, John A., Ross, David J., Ahmad, Shahzad, Saggar, Rajan, Libre, Eric, Lynch, Joseph P., Zisman, David A.
Publicado em 2008

Benefits of Intensive Treadmill Exercise Training on Cardiorespiratory Function and Quality of Life in Patients With Pulmonary Hypertension

Por Chan, Leighton, Chin, Lisa M. K., Kennedy, Michelle, Woolstenhulme, Joshua G., Nathan, Steven D., Weinstein, Ali A., Connors, Gerilynn, Weir, Nargues A., Drinkard, Bart, Lamberti, James, Keyser, Randall E.
Publicado em 2013

Validation of a Method To Screen for Pulmonary Hypertension in Advanced Idiopathic Pulmonary Fibrosis*

Por Zisman, David A., Karlamangla, Arun S., Kawut, Steven M., Shlobin, Oksana A., Saggar, Rajeev, Ross, David J., Schwarz, Marvin I., Belperio, John A., Ardehali, Abbas, Lynch, Joseph P., Nathan, Steven D.
Publicado em 2008

Treatment of Sarcoidosis-Associated Pulmonary Hypertension: A Two-Center Experience

Por Barnett, Christopher F., Bonura, Eric J., Nathan, Steven D., Ahmad, Shahzad, Shlobin, Oksana A., Osei, Kwabena, Zaiman, Ari L., Hassoun, Paul M., Moller, David R., Barnett, Scott D., Girgis, Reda E.
Publicado em 2009

Lactic Acid Is Elevated in Idiopathic Pulmonary Fibrosis and Induces Myofibroblast Differentiation via pH-Dependent Activation of Transforming Growth Factor-β

Por Kottmann, Robert Matthew, Kulkarni, Ajit A., Smolnycki, Katie A., Lyda, Elizabeth, Dahanayake, Thinesh, Salibi, Rami, Honnons, Sylvie, Jones, Carolyn, Isern, Nancy G., Hu, Jian Z., Nathan, Steven D., Grant, Geraldine, Phipps, Richard P., Sime, Patricia J.
Publicado em 2012

Dysregulation of Galectin-3. Implications for Hermansky-Pudlak Syndrome Pulmonary Fibrosis

Por Cullinane, Andrew R., Yeager, Caroline, Dorward, Heidi, Carmona-Rivera, Carmelo, Wu, Hai Ping, Moss, Joel, O’Brien, Kevin J., Nathan, Steven D., Meyer, Keith C., Rosas, Ivan O., Helip-Wooley, Amanda, Huizing, Marjan, Gahl, William A., Gochuico, Bernadette R.
Publicado em 2014

Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis

Por Lederer, David J., Bradford, Williamson Z., Fagan, Elizabeth A., Glaspole, Ian, Glassberg, Marilyn K., Glasscock, Kenneth F., Kardatzke, David, King, Talmadge E., Lancaster, Lisa H., Nathan, Steven D., Pereira, Carlos A., Sahn, Steven A., Swigris, Jeffrey J., Noble, Paul W.
Publicado no Chest (2015)

Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms

Por El-Chemaly, Souheil, Malide, Daniela, Zudaire, Enrique, Ikeda, Yoshihiko, Weinberg, Benjamin A., Pacheco-Rodriguez, Gustavo, Rosas, Ivan O., Aparicio, Marta, Ren, Ping, MacDonald, Sandra D., Wu, Hai-Ping, Nathan, Steven D., Cuttitta, Frank, McCoy, J. Philip, Gochuico, Bernadette R., Moss, Joel
Publicado em 2009

Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials

Por Lancaster, Lisa, Albera, Carlo, Bradford, Williamson Z, Costabel, Ulrich, du Bois, Roland M, Fagan, Elizabeth A, Fishman, Robert S, Glaspole, Ian, Glassberg, Marilyn K, King, Talmadge E, Lederer, David J, Lin, Zhengning, Nathan, Steven D, Pereira, Carlos A, Swigris, Jeffrey J, Valeyre, Dominique, Noble, Paul W
Publicado no BMJ Open Respir Res (2016)

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials

Por Noble, Paul W., Albera, Carlo, Bradford, Williamson Z., Costabel, Ulrich, du Bois, Roland M., Fagan, Elizabeth A., Fishman, Robert S., Glaspole, Ian, Glassberg, Marilyn K., Lancaster, Lisa, Lederer, David J., Leff, Jonathan A., Nathan, Steven D., Pereira, Carlos A., Swigris, Jeffrey J., Valeyre, Dominique, King, Talmadge E.
Publicado no Eur Respir J (2016)